Find clinical trials for Leukemia in Madrid, MD

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

Acute Myeloid Leukemia

B-Cell Chronic Lymphocytic Leukemia

Precursor Cell Lymphoblastic Leukemia-Lymphoma

Myeloid Leukemia

Myelodysplastic Syndromes

Lymphoid Leukemia

Lymphoma

Leukemia trials near Madrid, MD, ESP:

First in Human Study of Ziftomenib in Relapsed or Refractory Acute Myeloid Leukemia

in patients with relapsed or refractory (R/R) acute myeloid leukemia (AML). The main study has completed enrollment.In Sub-studies 1 and 2...

Active, not recruiting

Acute Leukemia of Ambiguous Lineage

Mixed Phenotype Acute Leukemia

Drug: Ziftomenib

Drug: Itraconazole

Phase 1, Phase 2

Kura Oncology

Madrid, Spain and 43 other locations

Study to Compare Azacitidine Plus Pevonedistat Versus Azacitidine in Patients With Acute Myeloid Leukemia Not Eligible for Standard Chemotherapy (PEVOLAM)

a standard of care for patients with newly diagnosed acute myeloid leukemia not eligible for intensive chemotherapy (thus not eligible for a...

Active, not recruiting

Leukemia, Myeloid, Acute

Drug: Pevonedistat

Drug: Azacitidine

Phase 3

PETHEMA Foundation

Madrid, Spain and 61 other locations

Safety and Efficacy of Ponatinib for Treatment of Pediatric Recurrent or Refractory Leukemias, Lymphomas or Solid Tumors

this study is to evaluate the safety, tolerability, pharmacokinetics, and efficacy of ponatinib in children aged 1 to \< 18 years with advanced leukemias...

Enrolling

Accelerated Phase Chronic Myeloid Leukemia

Acute Lymphocytic Leukemia

Drug: Ponatinib

Phase 1, Phase 2

Incyte

Madrid, Spain and 24 other locations

Clinical Trial to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Tuspetinib (HM43239) in Patients With Relapsed or Refractory Acute Myeloid Leukemia (TUSCANY)

in future studies in study participants diagnosed with acute myeloid leukemia (AML), myelodysplastic syndromes with increased blasts grade 2...

Enrolling

Leukemia, Myeloid, Acute

Chronic Myelomonocytic Leukemia

Drug: Venetoclax Oral Tablet

Drug: Tuspetinib

Phase 1, Phase 2

Aptose Biosciences

Pozuelo de Alarcón, Madrid, Spain and 33 other locations

IMGN632 as Monotherapy or With Venetoclax and/or Azacitidine for Participants With CD123-Positive Acute Myeloid Leukemia

This is an open-label, multicenter, Phase 1b/2 study to determine the safety and tolerability of IMGN632 and assess the antileukemia activity of IMGN...

Active, not recruiting

Acute Myeloid Leukemia

Drug: Azacitidine

Drug: IMGN632

Phase 1, Phase 2

AbbVie

Madrid, Spain and 28 other locations

A Phase 1/2 Study of Enzomenib (DSP-5336) in Patients With Acute Leukemia (Horizen-1)

A phase 1/2 dose escalation / dose expansion study of Enzomenib (DSP-5336) in patients with acute leukemia....

Enrolling

Leukemia, Lymphocytic, Acute

Leukemia, Myeloid, Acute

Drug: azoles

Drug: Gilteritinib

Phase 1, Phase 2

Sumitomo Pharma

Madrid, Spain and 103 other locations

A Study of Cusatuzumab Plus Azacitidine in Participants With Newly Diagnosed Acute Myeloid Leukemia Who Are Not Candidates for Intensive Chemotherapy (CULMINATE)

this study is to determine the efficacy of cusatuzumab in combination with azacitidine in participants with previously untreated acute myeloid leukemia...

Active, not recruiting

Leukemia, Myeloid, Acute

Drug: Cusatuzumab

Drug: Azacitidine

Phase 2

OncoVerity

Madrid, Spain and 56 other locations

A Study of Emavusertib + An Approved Bruton Tyrosine Kinase Inhibitor (BTKi) in Participants With Chronic Lymphocytic Leukemia (CLL) and Other B-cell Malignancies

The primary objective of the study for Cohort 1 and Cohort 2 is to assess the anticancer activity of emavusertib in combination with zanubrutinib in...

Enrolling

Chronic Lymphocytic Leukemia

B-cell Malignancies

Drug: Emavusertib

Drug: Zanubrutinib

Phase 2

Curis

Madrid, Spain and 6 other locations

A Study to Assess the Safety and Efficacy of Two Combinations of Isocitrate Dehydrogenase (IDH) Mutant Targeted Therapies Plus Azacitidine in Participants With Newly Diagnosed Acute Myeloid Leukemia (AML) Harboring IDH Mutations Who Are Not Candidates to Receive Intensive Induction Chemotherapy

of the combinations of AG-120 with azacitidine and AG-221 with azacitidine versus with azacitidine alone in participants with acute myeloid leukemia...

Active, not recruiting

Leukemia, Myeloid, Acute

Drug: Azacitidine

Drug: AG-120

Phase 1, Phase 2

Celgene

Madrid, Spain and 48 other locations

A Phase 1/2 Clinical Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Efficacy of TERN-701 in Participants With Chronic Myeloid Leukemia (CARDINAL)

participants with previously treated chronic phase - chronic myeloid leukemia (CP-CML).The study has two parts: Part 1 of the trial (Dose Es...

Enrolling

Chronic Myeloid Leukemia

Chronic Myeloid Leukemia, Chronic Phase

Drug: TERN-701

Phase 1, Phase 2

Terns Pharmaceuticals

Madrid, Spain and 53 other locations

Clinical trials

Find clinical trials Trials by location

Research sites

Find research sites Learn about CTV for professionals

Resources

Contact CTV support

Legal

Privacy Notice Terms

Find clinical trials for Leukemia in .css-epvm6{white-space:nowrap;}Madrid, MD

Related conditions:

Leukemia trials near Madrid, MD, ESP:

First in Human Study of Ziftomenib in Relapsed or Refractory Acute Myeloid Leukemia

Study to Compare Azacitidine Plus Pevonedistat Versus Azacitidine in Patients With Acute Myeloid Leukemia Not Eligible for Standard Chemotherapy (PEVOLAM)

Safety and Efficacy of Ponatinib for Treatment of Pediatric Recurrent or Refractory Leukemias, Lymphomas or Solid Tumors

Clinical Trial to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Tuspetinib (HM43239) in Patients With Relapsed or Refractory Acute Myeloid Leukemia (TUSCANY)

IMGN632 as Monotherapy or With Venetoclax and/or Azacitidine for Participants With CD123-Positive Acute Myeloid Leukemia

A Phase 1/2 Study of Enzomenib (DSP-5336) in Patients With Acute Leukemia (Horizen-1)

A Study of Cusatuzumab Plus Azacitidine in Participants With Newly Diagnosed Acute Myeloid Leukemia Who Are Not Candidates for Intensive Chemotherapy (CULMINATE)

A Study of Emavusertib + An Approved Bruton Tyrosine Kinase Inhibitor (BTKi) in Participants With Chronic Lymphocytic Leukemia (CLL) and Other B-cell Malignancies

A Study to Assess the Safety and Efficacy of Two Combinations of Isocitrate Dehydrogenase (IDH) Mutant Targeted Therapies Plus Azacitidine in Participants With Newly Diagnosed Acute Myeloid Leukemia (AML) Harboring IDH Mutations Who Are Not Candidates to Receive Intensive Induction Chemotherapy

A Phase 1/2 Clinical Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Efficacy of TERN-701 in Participants With Chronic Myeloid Leukemia (CARDINAL)

Find clinical trials for Leukemia in Madrid, MD